(600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 600223 · · 11 pages · Chinese
Lushang Freda Pharmaceutical Co., Ltd. on 6ix
Earlier from Lushang Freda Pharmaceutical
- (600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Appointment of Senior Executives
- (600223)"LUSHANG FREDA PHARMACEUTICAL CO., LTD."Announcement on Departure of Director and Senior Executive
- Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026
- Announcement on Completion of Transfer Registration of Certain Company Shares by the Controlling Shareholder through Agreement
- Notice on Convening the 2nd Extraordinary General Meeting in 2026
Follow Lushang Freda Pharmaceutical into a list and get an email when it puts out news.
Follow Lushang Freda Pharmaceutical